Clinical efficacy of Qianmitong in the treatment of Chronic prostatitis with qi-stagnancy and blood stasis Syndrome
- Conditions
- Chronic prostatitis
- Registration Number
- ITMCTR2100004846
- Lead Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
1. Those who meet the diagnostic criteria of chronic prostatitis can be used as test cases;
2. Age between 18-50 years old;
3. Those who have received treatment stop using all related drugs for the treatment of prostatitis for more than 2 weeks;
4. Volunteer to participate in the treatment and sign the trial informed consent.
1. Complicated with abnormal development of the genitourinary system;
2. Accompanied by diseases such as urinary tract infection and prostate tuberculosis;
3. Accompanied by prostate hyperplasia, prostate tumor, severe neurosis and other diseases;
4. Other diseases in the lower abdomen, perineum, lumbosacral and other parts with local pain as the main manifestation have not been ruled out;
5. Combined with severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, and mental illness;
6. Other situations where it is not possible to participate in the research in the whole process.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prostatic fluid cell influencing factor;Chronic prostatitis symptom index;
- Secondary Outcome Measures
Name Time Method Expressed prostatic secretion;TCM syndrome score table;